Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Head and Neck Cancer

Free Subscription 17.10.2022 7 Ann Surg 2 Br J Oral Maxillofac Surg 2 Clin Nucl Med 2 Dis Esophagus 1 Gastrointest Endosc 15 Head Neck 1 Histopathology 2 Int J Cancer 2 Int J Radiat Oncol Biol Phys 2 J Clin Oncol 1 J Nucl Med 1 J Oral Maxillofac Surg 1 Oral Oncol 1 PLoS One 1 Radiother Oncol 3 Surgery 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Surg

1. DONLON NE, Moran B, Kamilli A, Davern M, et al
   CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
   Ann Surg. 2022;276:792-798.
   PubMed         Abstract available
   
   
2. PERA M, Gibert J, Gimeno M, Garsot E, et al
   Machine Learning Risk Prediction Model of 90-day Mortality After Gastrectomy for Cancer.
   Ann Surg. 2022;276:776-783.
   PubMed         Abstract available
   
   
3. COOLS-LARTIGUE J, Markar S, Mueller C, Hofstetter W, et al
   An International Cohort Study of Prognosis Associated With Pathologically Complete Response Following Neoadjuvant Chemotherapy Versus Chemoradiotherapy of Surgical Treated Esophageal Adenocarcinoma.
   Ann Surg. 2022;276:799-805.
   PubMed         Abstract available
   
   
4. WANG S, Huang S, Gao Z, Zhuang W, et al
   Comment on: The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-Negative Esophageal Adenocarcinoma.
   Ann Surg. 2022;276:e645.
   PubMed        
   
   
5. OKAMURA A, Yamamoto H, Watanabe M, Miyata H, et al
   Association Between Preoperative HbA1c Levels and Complications after Esophagectomy: Analysis of 15,801 Esophagectomies From the National Clinical Database in Japan.
   Ann Surg. 2022;276:e393-e399.
   PubMed         Abstract available
   
   
6. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
   The Complexity of Defining Postoperative Pneumonia After Esophageal Cancer Surgery: A Spectrum of Lung Injury Rather Than a Simple Infective Complication?
   Ann Surg. 2022;276:e400-e406.
   PubMed         Abstract available
   
   
7. KINGMA BF, Grimminger PP, van der Sluis PC, van Det MJ, et al
   Worldwide Techniques and Outcomes in Robot-assisted Minimally Invasive Esophagectomy (RAMIE): Results From the Multicenter International Registry.
   Ann Surg. 2022;276:e386-e392.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

8. CHEGINI S, Sassoon I, McGurk M
   Extracapsular dissection (ECD) and extended ECD: description of the technique and outcome of treatment.
   Br J Oral Maxillofac Surg. 2022;60:1062-1067.
   PubMed         Abstract available
   
   
9. MCGOLDRICK DM, Edwards J, Abdelrahman A, Praveen P, et al
   Admission patterns and outcomes of postoperative oral cavity and oropharyngeal cancer patients admitted to critical care in the UK: an analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database.
   Br J Oral Maxillofac Surg. 2022;60:1108-1113.
   PubMed         Abstract available
   
   

   
   Clin Nucl Med

10. LEDER T, Seifert P, Drescher R, Guhne F, et al
    Excellent Response to Multimodal Therapy Approach in Hyperfunctioning Metastatic Follicular Thyroid Carcinoma Diagnosed on 123I-SPECT/Ultrasound Fusion Imaging.
    Clin Nucl Med. 2022 Oct 14. pii: 00003072-990000000-00306.
    PubMed         Abstract available
    
    
11. DUARTE PS
    Re: Visualization of Tumor Heterogeneity in Advanced Medullary Thyroid Carcinoma by Dual-Tracer Molecular Imaging: Revealing the Theranostic Potential of SSTR- and PSMA-Directed Endoradiotherapy.
    Clin Nucl Med. 2022;47:e722.
    PubMed        
    
    

    
    Dis Esophagus

12. SCHURING N, Markar SR, Hagens ERC, Jezerskyte E, et al
    Health-related quality of life following neoadjuvant chemoradiotherapy versus perioperative chemotherapy and esophagectomy for esophageal cancer: a European multicenter study.
    Dis Esophagus. 2022 Oct 14. pii: 6761045. doi: 10.1093.
    PubMed         Abstract available
    
    
13. OZAWA H, Kawakubo H, Nishimura E, Matsuda S, et al
    Comparison of hand-sewn and circular stapled esophagogastric anastomoses in the neck after esophagectomy for thoracic esophageal cancer: a propensity score-matched analysis.
    Dis Esophagus. 2022 Oct 11. pii: 6758196. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Gastrointest Endosc

14. MINAMIDE T, Kawata N, Maeda Y, Yoshida M, et al
    Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2022 Oct 10. pii: S0016-5107(22)02035.
    PubMed         Abstract available
    
    

    
    Head Neck

15. CHEN R, Cai Q, Lin P, Liang F, et al
    Role of immune-inflamed phenotype in the prognosis of hypopharyngeal carcinoma following primary surgery.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27218.
    PubMed         Abstract available
    
    
16. SANSA A, Valero C, Holgado A, Vasquez R, et al
    External validation of the H-index (host index) in patients with head and neck squamous cell carcinomas.
    Head Neck. 2022 Oct 12. doi: 10.1002/hed.27224.
    PubMed         Abstract available
    
    
17. HOEBERS F, Yu E, O'Sullivan B, Postma AA, et al
    Augmenting inter-rater concordance of radiologic extranodal extension in HPV-positive oropharyngeal carcinoma: A multicenter study.
    Head Neck. 2022;44:2361-2369.
    PubMed         Abstract available
    
    
18. ZHANG D, Chai Y, Wei Y, Qi F, et al
    Survival and prognosis of metastatic head and neck adenoid cystic carcinoma.
    Head Neck. 2022;44:2407-2416.
    PubMed         Abstract available
    
    
19. ROMAN KM, Torabi SJ, Goshtasbi K, Kuan EC, et al
    Case volume regionalization and volume-based outcome differences in cutaneous head and neck melanoma.
    Head Neck. 2022;44:2428-2436.
    PubMed         Abstract available
    
    
20. LAN L, Wang D, Ma R, Wang W, et al
    Extracapsular dissection by the sternocleidomastoid muscle-parotid space approach reduces the risks of postparotidectomy sialocele and salivary fistula.
    Head Neck. 2022;44:2522-2527.
    PubMed         Abstract available
    
    
21. CHEN X, Kong D, Deng J, Mo F, et al
    Overexpression of circFNDC3B promotes the progression of oral tongue squamous cell carcinoma through the miR-1322/MED1 axis.
    Head Neck. 2022;44:2417-2427.
    PubMed         Abstract available
    
    
22. MISHRA A, Shankar R, Prakash G, Banerjee S, et al
    Transposition nasolabial flap: A versatile flap for sensate reconstruction of lip defects.
    Head Neck. 2022;44:2473-2480.
    PubMed         Abstract available
    
    
23. COSTANTINO A, Pace GM, Festa BM, Ferreli F, et al
    Salivary bypass tube in total laryngectomy: Systematic review and meta-analysis.
    Head Neck. 2022;44:2608-2620.
    PubMed         Abstract available
    
    
24. MILLER JA, Moradi F, Sundaram V, Liang R, et al
    Posttreatment FDG-PET/CT Hopkins criteria predict locoregional recurrence after definitive radiotherapy for oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:2491-2504.
    PubMed         Abstract available
    
    
25. TALWAR A, Gordon AJ, Bewley AF, Fancy T, et al
    Distribution of the head and neck surgical oncology workforce in the United States.
    Head Neck. 2022;44:2537-2544.
    PubMed         Abstract available
    
    
26. DE LEO AN, Dagan R, Morris CG, Holtzman AL, et al
    Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
    Head Neck. 2022;44:2513-2521.
    PubMed         Abstract available
    
    
27. VAN DEN BOSCH S, Czerwinski M, Govers T, Takes RP, et al
    Diagnostic test accuracy of sentinel lymph node biopsy in squamous cell carcinoma of the oropharynx, larynx, and hypopharynx: A systematic review and meta-analysis.
    Head Neck. 2022;44:2621-2632.
    PubMed         Abstract available
    
    
28. BAGUE S, Leon X, Terra X, Lejeune M, et al
    Prognostic capacity of the transcriptional expression of lactate dehydrogenase A in patients with head and neck squamous cell carcinoma.
    Head Neck. 2022;44:2505-2512.
    PubMed         Abstract available
    
    
29. GOODFELLOW M, Lim C, Tustin H, Mentias Y, et al
    The diagnostic yield of head and neck imaging in symptomatic patients with a normal clinical examination.
    Head Neck. 2022;44:2564-2570.
    PubMed         Abstract available
    
    

    
    Histopathology

30. XU B, Viswanathan K, Umrau K, Al-Ameri TAD, et al
    Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.
    Histopathology. 2022;81:670-679.
    PubMed         Abstract available
    
    

    
    Int J Cancer

31. SOROUSH A, Malekzadeh R, Roshandel G, Khoshnia M, et al
    Sex and smoking differences in the association between gastroesophageal reflux and risk of esophageal squamous cell carcinoma in a high-incidence area: Golestan Cohort Study.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34313.
    PubMed         Abstract available
    
    
32. MA Y, Li W, Chen S, Lin S, et al
    Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.
    Int J Cancer. 2022 Oct 10. doi: 10.1002/ijc.34315.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

33. BEADLE BM, Bauman JE
    Reconsidering How It Begins: Response to Gray Zone Article About Head and Neck Cancer in a Young Pregnant Woman.
    Int J Radiat Oncol Biol Phys. 2022 Sep 21. pii: S0360-3016(22)03321.
    PubMed        
    
    
34. GILLISON ML, Ferris RL, Harris J, Colevas AD, et al
    Safety of nivolumab added to chemoradiotherapy platforms for intermediate and high-risk local-regionally advanced head and neck squamous cell carcinoma: RTOG Foundation 3504.
    Int J Radiat Oncol Biol Phys. 2022 Oct 10. pii: S0360-3016(22)03434.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

35. HO AL
    Immunotherapy, Chemotherapy, or Both: Options for First-Line Therapy for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
    J Clin Oncol. 2022 Oct 12:JCO2201408. doi: 10.1200/JCO.22.01408.
    PubMed         Abstract available
    
    
36. HARRINGTON KJ, Burtness B, Greil R, Soulieres D, et al
    Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.
    J Clin Oncol. 2022 Oct 11:JCO2102508. doi: 10.1200/JCO.21.02508.
    PubMed         Abstract available
    
    

    
    J Nucl Med

37. HU X, Zhou T, Ren J, Duan J, et al
    Response prediction using (18)F-FAPI-04 PET/CT in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy.
    J Nucl Med. 2022 Oct 13. pii: jnumed.122.264638. doi: 10.2967/jnumed.122.264638.
    PubMed         Abstract available
    
    

    
    J Oral Maxillofac Surg

38. MCMILLAN DC, McMillan KB, Lee SKY, Vierkant RA, et al
    What is the Incidence of Oral Cancer Recurrence in Patients Reconstructed With a Microvascular Free Flap, Endosseous Implants, and an Oral Prosthesis and How Does the Timing of Implant Placement Influence Recurrence?
    J Oral Maxillofac Surg. 2022 Sep 10. pii: S0278-2391(22)00837.
    PubMed         Abstract available
    
    

    
    Oral Oncol

39. ZHU S, Zhang F, Zhao G, Zhang X, et al
    Trends in the global burden of oral cancer joint with attributable risk factors: Results from the global burden of disease study 2019.
    Oral Oncol. 2022;134:106189.
    PubMed         Abstract available
    
    

    
    PLoS One

40. HUR JY, Ku BM, Park S, Jung HA, et al
    Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
    PLoS One. 2022;17:e0274830.
    PubMed         Abstract available
    
    

    
    Radiother Oncol

41. RONN HANSEN C, Price G, Field M, Sarup N, et al
    Larynx cancer survival model developed through open-source federated learning.
    Radiother Oncol. 2022 Oct 5. pii: S0167-8140(22)04493.
    PubMed         Abstract available
    
    

    
    Surgery

42. HUMPHREYS BM, Memeh KO, Funkhouser A, Vaghaiwalla TM, et al
    Prognostic factors and survival analysis of Hurthle cell carcinoma: A population-based study.
    Surgery. 2022;172:1379-1384.
    PubMed         Abstract available
    
    
43. CONROY PC, Wilhelm A, Calthorpe L, Ullmann TM, et al
    Endocrine surgeons are performing more thyroid lobectomies for low-risk differentiated thyroid cancer since the 2015 ATA guidelines.
    Surgery. 2022 Aug 21. pii: S0039-6060(22)00498.
    PubMed         Abstract available
    
    
44. LIANG W, Shi J, Zhang H, Lv G, et al
    Total thyroidectomy vs thyroid lobectomy for localized medullary thyroid cancer in adults: A propensity-matched survival analysis.
    Surgery. 2022 Aug 19. pii: S0039-6060(22)00489.
    PubMed         Abstract available
    
    

    
    Thyroid

45. DUVAL MADS, Ferreira CV, Marmitt L, Dora JM, et al
    An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma: Results of a retrospective cohort study.
    Thyroid. 2022 Oct 12. doi: 10.1089/thy.2022.0295.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: